ALXO·00166B105·US·equity·Healthcare - Biotechnology-Activist
ALXO (ALX ONCOLOGY HLDGS INC) is held by 41 institutional investors as of Q1 2026. Largest holders: RA CAPITAL MANAGEMENT, L.P. ($26.1M), Blackstone Inc. ($11.7M), DRIEHAUS CAPITAL MANAGEMENT LLC ($11.5M). Net institutional sentiment: Bullish.
See how ALXO's score breaks down across 4 SEC sources
Showing 1-20 of 48
Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer